Bazedoxifene Conjugated Estrogens (Duavive) shortage status
Partial shortage
Source: Health Canada shortage reports · Updated Aug 18, 2026
Some Bazedoxifene Conjugated Estrogens products are in shortage in Canada (1 of 1 reported products), while others remain available. Your pharmacy may be able to substitute an unaffected manufacturer. The latest estimate for affected products to return is Sep 11, 2026.
A combination used to treat menopausal symptoms and help prevent osteoporosis.
Products affected
1 / 1
In shortage since
Aug 13, 2026
Est. full return
Sep 11, 2026
Reports on file
5
Talk to a pharmacist
Pharmacists can substitute an unaffected manufacturer's version, adjust strengths, and in most provinces adapt or renew a prescription on the spot.
Independent services, not affiliated with rxstat; referral fees may apply. Free options exist depending on your province. In an emergency call 911; free health advice at 811.
Shortage history
Shortage history (red bands = periods in shortage).
DIN 02432854 · ended Jun 9, 2023 · Disruption of the manufacture of the drug.
What's happening
Bazedoxifene Conjugated Estrogens is currently affected by an active shortage report filed with Health Canada by PFIZER CANADA ULC.
The reported cause is: disruption of the manufacture of the drug. Manufacturers must report shortages, but end-date estimates are their own projections and often move.
If your usual product is affected, a pharmacist is the fastest route to a solution: they can dispense an unaffected manufacturer's equivalent when one exists, and in most provinces can adapt doses or substitute a therapeutic alternative without a new appointment.
Bazedoxifene Conjugated Estrogens is classified under “ESTROGENS” (ATC G03CC).
Recent changes
Aug 18, 2026
Status changed
Jul 29, 2026
New report filed
Common questions
What is Bazedoxifene Conjugated Estrogens used for?
A combination used to treat menopausal symptoms and help prevent osteoporosis.
When will Bazedoxifene Conjugated Estrogens be back in stock in Canada?
The latest manufacturer estimate is Sep 11, 2026. Estimates are self-reported and often slip; this page updates automatically when they change.
Why is Bazedoxifene Conjugated Estrogens in shortage?
See the reports above; manufacturers must state a reason (most commonly manufacturing disruption or a surge in demand) when filing with Health Canada.
What can my pharmacist do about it?
Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.
Email alerts
Get an email when this drug's status changes. Double opt-in, one-click unsubscribe.
Possible alternatives in the same class (estrogens)
Drugs in the same therapeutic class, best-supplied first. These are not automatic substitutes: only your pharmacist or prescriber can judge whether a switch makes sense for you.
Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.